![](/img/cover-not-exists.png)
Are routine prophylactic dalteparin doses appropriate in patients undergoing head and neck cancer resection and reconstruction?
S.E. BondVolume:
38
Year:
2009
Language:
english
DOI:
10.1016/j.ijom.2009.03.655
File:
PDF, 85 KB
english, 2009